Morice R, Urbanc S, McNicol D
Aust N Z J Psychiatry. 1985 Dec;19(4):390-5. doi: 10.3109/00048678509158847.
The Premorbid Adjustment Scale (PAS) is a new premorbid scale for use in schizophrenia, developed by the National Institute of Mental Health. Its use in a recent Australian study is described. While total scores clearly discriminated schizophrenic from manic patients, and good test-retest reliability was demonstrated for the schizophrenic patients, the scores did not predict duration of hospitalisation for the schizophrenic group, as reported in the North American study. It is concluded that more research on the PAS is necessary before it can be accepted as a useful instrument in schizophrenia research and clinical practice.
病前适应量表(PAS)是美国国立精神卫生研究所开发的一种用于精神分裂症的新型病前量表。本文描述了其在最近一项澳大利亚研究中的应用情况。虽然总分能清晰地区分精神分裂症患者和躁狂症患者,并且对精神分裂症患者显示出良好的重测信度,但正如北美研究报告的那样,这些分数并不能预测精神分裂症组的住院时长。得出的结论是,在PAS被接受为精神分裂症研究和临床实践中的有用工具之前,有必要对其进行更多研究。